Prasugrel Tablet, Film Coated
Product Images NDC 60505-4642

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 60505-4642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 01

Chemical structure diagram of the active ingredient prasugrel, showing its molecular arrangement including rings and functional groups.*

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 02

A Kaplan-Meier curve comparing the percentage of non-CABG-related TIMI major or minor bleeding events over days from randomization between Prasugrel tablets and Clopidogrel. The x-axis shows days from 0 to 450, and the y-axis shows event percentage from 0 to 5%. The graph includes a smaller inset chart depicting a similar comparison for the first 7 days. Numbers at risk are listed below for both treatments at multiple time points.*

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 03

A line chart depicting inhibition of platelet aggregation (%) over time (hours) with data points and error bars representing mean ± standard deviation for 20 µM ADP. The graph shows rapid increase in inhibition within the first few hours stabilizing around 80% and remains relatively constant up to 24 hours.*

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 04

A Kaplan-Meier curve chart compares the incidence percentage of cardiovascular death, nonfatal myocardial infarction (MI), or nonfatal stroke over days from randomization between Prasugrel Tablets and Clopidogrel in patients with UA/NSTEMI. The chart shows lower event rates for Prasugrel Tablets. A smaller inset graph illustrates a similar comparison with a shorter timeline.*

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 05

A line graph comparing cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke percentages over 450 days from randomization between Prasugrel Tablets and Clopidogrel in STEMI patients. The graph includes a smaller inset graph showing data for the first 7 days with p-values of 0.02 and 0.008, respectively.*

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 06

A forest plot showing baseline characteristics and percent event rates comparing Prasugrel tablets versus Clopidogrel. The plot displays subgroup analyses by age, gender, body weight, region, diabetes status, metabolic syndrome, previous cardiovascular events, time from symptom onset, stent type, and GP IIb/IIIa inhibitor use. Hazard ratios with confidence intervals are plotted, indicating relative effectiveness of Prasugrel and Clopidogrel in various patient categories.*

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 07

A forest plot showing hazard ratios comparing prasugrel tablets and clopidogrel across various baseline characteristics and subgroups. The plot illustrates percent events and hazard ratios with confidence intervals for factors such as age, gender, body weight, region, diabetes, metabolic syndrome, previous cardiovascular events, time from symptom onset, stent type, and inhibitor use.*

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 08

Prasugrel Tablets 5 mg film-coated oral tablets supplied in a 30-count container. Label indicates prescription use only and includes storage instructions and manufacturer details. The round, light brown tablet is shown with the imprint '5'. Labeler is Apotex Corp., with manufacturing by Panacea Biotec Pharma Limited in India.*

FDA Label Image

2bdfb562 E6ba 467f 85fb 0004741f04fb 09

Prasugrel Tablets 10 mg film-coated oral tablets label showing 30 tablets per container. The label includes the NDC 60505-4643-3 and states each tablet contains prasugrel hydrochloride equivalent to 10 mg prasugrel. Manufactured by Panacea Biotec Pharma Limited for Apotex Corp. Storage instructions and dispensing warnings are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.